Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If they had hired a couple of high school math kids to do the financials they could have been finished months ago. I’m just about tired of waiting on these incompetent morons.
Will this be the BIG NEWSweek?
Correct on that. And what about the theory "C-19 is a Chinese hoax/it will be gone in a month/masks are for the weak, they hurt the economy" BS that so many believed in?
President and the First Lady are just the beginning of the story...
The tracing of this is gonna be huge. White House outbreak sooner than later. All of the people that have come in contact recently will keep expanding. Just the White House alone has many tight corners besides others that visited.
Yesterday I said “I’ve been in biotechs for 33 years” and should have said ‘been in biotech Investing’ . I received a couple of PM’s assuming I worked in that field. Sorry for that misleading statement. I did have a career in the pharmaceutical field.
PM,s asked for my thoughts re positive results between RVV and it’s similar ‘competitor’. I don’t have PM privileges but I own both and have always followed the old Yogi phrase “it’s not over till it’s over”, I.e. phase 3 results. Biotech investing is a Fun gambling hobby for me & I only play with money I can afford to lose. It also rejuvenates by brain cells, at times making them angry
I've been in biotechs for 33 years and have learned to ignore teenagers who yell & scream in bold.
Loading and holding?.
Vitamin D is NOT a Covid CURE. Fact.
Bottom feeding lawyers stifle important new products in US ?Posted by investor2014.
Covering all exclusions to defend against litigation is why a number of companies are deciding not to enter or to withdraw their products from the litigious U.S. market.
The analogue example is when PA regs or Missling fails to explicitly exclude some possibility, then someone will immediately think of some unlikely event and claim it is possible or even guaranteed to occur.
A Danish manufacturer withdrew a well proven and respected heart starter from the U.S. market because of the risk of litigation and high probability of loosing in court should someone use it in any number of unforeseeable stupid ways injuring themselves, others or simply failing to restart someone’s heart costing the company untold millions of dollars in settlements.
There was also the case of a woman who decided to dry her rain vet cat in the microwave oven. The cat, not unsurprisingly to most, died and she sued the microwave manufacturer and won because the instructions did not explicitly state not to dry one’s cat in it.
“A little bit of news”. That is huge news if Leo is following the protocol we had at the pharma company I worked with for 35 years. The company only hired a Clinical Trials Director if a ‘myfloxanub’ killed most or all of the bad bugs in a Petri dish and top decision makers had high confidence in final results.
Geeze. Does that include the SELL advice at .08?
I bypass the yelling.
RVVTF Is A Cheap COVID-19 Play-Insider Financial
https://insiderfinancial.com/rvvtf-is-a-cheap-covid-19-play/180441/
RVVTF Is A Cheap CIVID-19 PlayInsider Financial
https://insiderfinancial.com/rvvtf-is-a-cheap-covid-19-play/180441/
If so, I sure hope it’s that TRIFECTA of news we’ve been expecting for two years.
Yesterday was a good day for CYDY. Many weak hands who couldn’t distinguish a biotech from a Bamboo jumped overboard and cleared way for those of us who do. I’ve said many times over my 35 years of biotech investing that 80% of ‘investors’ shouldn’t be in bios.
Yes , you are correct. Sorry for my previous post to you. Got my boards confused. I thought you were a poster on a stock board whose pps is at 0.025 lol.
Yeah, uh, ok.
Only 23% of citizens had any confidence in Trumps ‘Covid Treatments’ during his first Round of White House Corona Pressers , haven’t seen the numbers on second round, but have heard from many who say they will not take the vaccine. If we (Revive) are successful I would hope we wouldn’t suffer negative consequences if mentioned from the WH.
IMO, illegal manipulators along with 80% of biotech 'investors' having no clue regarding the possibilities here. They look at this stock as just another 'widget' company-drawing plans this week, manufacturing it next week, and marketing it the next. Sad.
Novice trader here, Why would this press not raise the SP? No real money? I remember it bounced to 0.65 on seeming lesser news not too long ago.
Excellent!
Link please.
Notice I corrected my previous post adding too ignorant to ‘NOT ‘buy in the teens. I’m not a rocket scientist but I did have enough Intelligence to load up in the teens and low twenties.
I would be puking now also if I had been too ignorant to not buy in the teens,lol.
Just forwarded your post to the SEC for confirmation.
Yes IMO. Also when corruption and lies are exposed, perps are outed to the public, then perps yell 'fake news'. So, is that the status of RLFTF , or not?
Fake news? Isn’t that the same argument someone uses to create distrust in opposing outside thoughts and theories?
.23 is a brick wall? I thought .08 was the real brick wall. Thoughts?
Wow, .2 3? I thought the brick was was .08.
Are patient’s continuing to be accepted into NWBO trials?
Wow, I bet all those expert analysts at all those huge brokerage houses who have $16 plus targets for SRNE would love to know this,lol.
WAKEFIELD, MA – August 24, 2020 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, reports today receiving additional data from a U.S. Regional Biocontainment Laboratory (RBL) based on ongoing in vitro testing supporting Brilacidin as a potential treatment for SARS-CoV-2, the novel coronavirus responsible for COVID-19.
“The latest Brilacidin in vitro efficacy results against SARS-CoV-2 are outstanding,” noted Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals. “Selectivity Index is arguably the most important measure to compare the antiviral efficacy between experimental drugs and this new data suggests Brilacidin is in an elite group of anti-coronavirus candidates. For a point of reference, a SI greater than 100 is considered exceptional. Unlike thousands of other compounds and drugs under consideration as COVID-19 treatments, Brilacidin is demonstrating remarkably consistent and potent anti-SARS-CoV-2 activity in RBL testing, suggesting Brilacidin has tremendous potential as a COVID-19 treatment. We are actively planning to get Brilacidin into human testing as fast as possible, following necessary approvals and set-up procedures.”
In a new experiment at the RBL in a human lung epithelial cell line, Brilacidin, when directly incubated with the live (or wild type) virus, was shown to inhibit the virus by 50 percent (the IC50 value) at a mid-nanomolar concentration, while remaining non-cytotoxic to cells at high micromolar concentrations—establishing a SI for Brilacidin greater than 300 in this lung cell line. Additionally, this new testing in the human lung cell line showed Brilacidin’s IC90 value to be in the low micromolar range.
Based on public information (https://ghddi-ailab.github.io/Targeting2019-nCoV/preclinical/), a vast majority of other drugs being evaluated as COVID-19 treatments, including repurposed drugs, have SIs that are much lower than that achieved by Brilacidin. Moreover, according to a recent screening of 5,632 compounds (https://www.researchsquare.com/article/rs-23951/v1), including 3,488 compounds that have undergone clinical stage testing across 600 indications, only 19 compounds were identified as having an IC50 in the nanomolar (<1µM) range, as Brilacidin achieved, when tested against SARS-CoV-2.
Brilacidin has now exhibited robust in vitro anti-SARS-CoV-2 efficacy at low concentrations, well below already established clinically-achievable concentrations based on pharmacokinetics observed in the Company’s Phase 2b clinical trial of Brilacidin in Acute Bacterial Skin and Skin Structure Infections.
In other news, the Company is preparing to expedite planned clinical testing of Brilacidin for COVID-19, including identification of clinical trial sites. Interactions with the Food and Drug Administration, through its Coronavirus Treatment Acceleration Program, are anticipated to begin early September, along with the selection of a Contract Research Organization to implement the Brilacidin for COVID-19 clinical trial. Lastly, the manufacturing of Brilacidin intravenous (IV) drug product is expected to produce an amount in excess of what is estimated to be required for the Company’s planned Phase 2 clinical trial, allowing for extra IV drug product to support potential additional COVID-19 clinical testing.
Global COVID-19 Cases and Mortality
Correct oldprof. It's a sad day in this country when politics preempts science with a 35% efficacy EUA drug and a 97% efficacy drug (brilacidin) sits in a lab as patients die. This tells all:
https://www.pogo.org/analysis/2020/08/corrupted-will-cronyism-and-politics-hamper-the-vaccine-program/
Corruption in the Covid vaccine business? Who would have ever thought?
https://www.pogo.org/analysis/2020/08/corrupted-will-cronyism-and-politics-hamper-the-vaccine-program/
Is this possible to reach $15 billion in sales if approved ?
Can anyone explain the total ignorance of 'investors' here? Did they misread the COVI-GUARD IND PR ?
Sorrento Therapeutics Inc. shares were down 12% at $10.89 after the company said it is filing an investigational new drug application for COVI-GUARD STI-1499 for hospitalized Covid-19 patients.
Wortless.
I just forwarded to the SEC enforcement section for an answer. Will let you know when I hear something.
Teens??? I thought it was .08 predicted weeks ago!!!
Correct, and they have been manipulating this stock for years. I know because I was in this stock for years, sold out for a loss a year ago, bought back in a few months ago. I've enjoyed reporting them to the do-nothing SEC for fun hoping they (SEC) just might take action on a few for fun .
the crooks and thieves know how to do it with impunity,
Please educate me re ‘A lot of folks lately don’t think much of it’s chances’. Do you mean folks like the perennial loser A. Fruitstain,lol? I can read and comprehend most of the articles pertaining to CDYN and my ‘guesstimate’ is Pro Leronlimab ones outnumber negative around 8-1.
The only “small group” I see that you refer to are NOT those who believe in the science & future of Leronlimab.
Is this the week for a TRIFECTA of news?